Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86–92.
Article
CAS
PubMed
Google Scholar
Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005;106(5 Pt 1):1071–83.
Article
PubMed
Google Scholar
Andersson L, Sundstrom-Poromaa I, Bixo M, Wulff M, Bondestam K. aStrom M. point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol. 2003;189(1):148–54.
Article
PubMed
Google Scholar
Gorman LL, O'Hara MW, Figueiredo B, Hayes S, Jacquemain F, Kammerer MH, et al. Adaptation of the structured clinical interview for DSM-IV disorders for assessing depression in women during pregnancy and post-partum across countries and cultures. Br J Psychiatry Suppl. 2004;46:s17–23.
Article
CAS
PubMed
Google Scholar
Melville JL, Gavin A, Guo Y, Fan MY, Katon WJ. Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample. Obstet Gynecol. 2010;116(5):1064–70.
Article
PubMed
PubMed Central
Google Scholar
Patkar AA, Bilal L, Masand PS. Pharmacotherapy of depression in pregnancy. Ann Clin Psychiatry. 2004;16(2):87–100.
Article
PubMed
Google Scholar
The National Board of Health and Welfare. Sweden 2016. (www.socialstyrelsen.se).
Huybrechts KF, Palmsten K, Mogun H, Kowal M, Avorn J, Setoguchi-Iwata S, et al. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry. 2013;35(3):265–71.
Article
PubMed
PubMed Central
Google Scholar
Kieler H. The Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy. Clin Epidemiol. 2010;2:205–7.
Article
PubMed
PubMed Central
Google Scholar
El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry. 2012;69(7):706–14.
Article
PubMed
Google Scholar
Petersen I, Peltola T, Kaski S, Walters KR, Hardoon S. Depression, depressive symptoms and treatments in women who have recently given birth: UK cohort study. BMJ Open. 2018;8(10):e022152.
Article
PubMed
PubMed Central
Google Scholar
Charlton RA, Jordan S, Pierini A, Garne E, Neville AJ, Hansen AV, et al. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions. BJOG. 2015;122(7):1010–20.
Article
CAS
PubMed
Google Scholar
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350:h1798.
Article
PubMed
PubMed Central
Google Scholar
Olivier JD, Akerud H, Kaihola H, Pawluski JL, Skalkidou A, Hogberg U, et al. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci. 2013;7:73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prady SL, Hanlon I, Fraser LK, Mikocka-Walus A. A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring's outcomes. Arch Womens Ment Health. 2018;21(2):127–40.
Wang YZ, S. Chapter 3, structure of the placenta. In: Vascular biology of the placenta. Morgan & Claypool Life Sciences: San Rafael (CA); 2010.
Chapter
Google Scholar
Audette MC, Kingdom JC. Screening for fetal growth restriction and placental insufficiency. Semin Fetal Neonatal Med. 2018;23(2):119–25.
Article
PubMed
Google Scholar
Hodyl NA, Aboustate N, Bianco-Miotto T, Roberts CT, Clifton VL, Stark MJ. Child neurodevelopmental outcomes following preterm and term birth: what can the placenta tell us? Placenta. 2017;57:79–86.
Article
CAS
PubMed
Google Scholar
Sultana Z, Maiti K, Dedman L, Smith R. Is there a role for placental senescence in the genesis of obstetric complications and fetal growth restriction? Am J Obstet Gynecol. 2018;218(2S):S762–S73.
Article
PubMed
Google Scholar
Reijnders IF, Mulders A, Koster MPH. Placental development and function in women with a history of placenta-related complications: a systematic review. Acta Obstet Gynecol Scand. 2018;97(3):248–57.
Article
PubMed
Google Scholar
Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160(5):993–6.
Article
PubMed
Google Scholar
Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, DeVane CL, et al. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry. 2006;163(1):145–7.
Article
PubMed
Google Scholar
Cikos S, Fabian D, Makarevich AV, Chrenek P, Koppel J. Biogenic monoamines in preimplantation development. Hum Reprod. 2011;26(9):2296–305.
Article
PubMed
Google Scholar
Oufkir T, Arseneault M, Sanderson JT, Vaillancourt C. The 5-HT 2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines. Placenta. 2010;31(5):439–47.
Article
CAS
PubMed
Google Scholar
Charnock-Jones DS, Burton GJ. Placental vascular morphogenesis. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(6):953–68.
Article
CAS
PubMed
Google Scholar
Bhuiyan M, Petropoulos S, Gibb W, Matthews SG. Sertraline alters multidrug resistance phosphoglycoprotein activity in the mouse placenta and fetal blood-brain barrier. Reprod Sci. 2012;19(4):407–15.
Article
CAS
PubMed
Google Scholar
Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, et al. A transient placental source of serotonin for the fetal forebrain. Nature. 2011;472(7343):347–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gentile S, Fusco ML. Placental and fetal effects of antenatal exposure to antidepressants or untreated maternal depression. J Matern Fetal Neonatal Med. 2017;30(10):1189–99.
Article
CAS
PubMed
Google Scholar
Kaihola H, Olivier J, Poromaa IS, Akerud H. The effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta. PLoS One. 2015;10(1):e0116459.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olivier JD, Akerud H, Skalkidou A, Kaihola H, Sundstrom-Poromaa I. The effects of antenatal depression and antidepressant treatment on placental gene expression. Front Cell Neurosci. 2014;8:465.
PubMed
Google Scholar
Kumsta R, Hummel E, Chen FS, Heinrichs M. Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience. Front Neurosci. 2013;7:83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Simons RL, Lei MK, Beach SRH, Cutrona CE, Philibert RA. Methylation of the oxytocin receptor gene mediates the effect of adversity on negative schemas and depression. Dev Psychopathol. 2017;29(3):725–36.
Article
PubMed
Google Scholar
Galbally M, Ryan J. Van IM, Watson SJ, Spigset O, Lappas M, et al. maternal depression, antidepressant use and placental oxytocin receptor DNA methylation: findings from the MPEWS study. Psychoneuroendocrinology. 2018;90:1–8.
Article
CAS
PubMed
Google Scholar
Janssen AB, Capron LE, O'Donnell K, Tunster SJ, Ramchandani PG, Heazell AE, et al. Maternal prenatal depression is associated with decreased placental expression of the imprinted gene PEG3. Psychol Med. 2016;46(14):2999–3011.
Article
CAS
PubMed
PubMed Central
Google Scholar
Capron LE, Ramchandani PG, Glover V. Maternal prenatal stress and placental gene expression of NR3C1 and HSD11B2: the effects of maternal ethnicity. Psychoneuroendocrinology. 2018;87:166–72.
Article
CAS
PubMed
Google Scholar
Togher KL, Treacy E, O'Keeffe GW, Kenny LC. Maternal distress in late pregnancy alters obstetric outcomes and the expression of genes important for placental glucocorticoid signalling. Psychiatry Res. 2017;255:17–26.
Article
CAS
PubMed
Google Scholar
Seth S, Lewis AJ, Saffery R, Lappas M, Galbally M. Maternal prenatal mental health and placental 11beta-HSD2 gene expression: initial findings from the mercy pregnancy and emotional wellbeing study. Int J Mol Sci. 2015;16(11):27482–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reynolds RM, Pesonen AK, O'Reilly JR, Tuovinen S, Lahti M, Kajantie E, et al. Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity. Psychol Med. 2015;45(10):2023–30.
Article
CAS
PubMed
Google Scholar
O'Donnell KJ, Bugge Jensen A, Freeman L, Khalife N, O'Connor TG, Glover V. Maternal prenatal anxiety and downregulation of placental 11beta-HSD2. Psychoneuroendocrinology. 2012;37(6):818–26.
Article
CAS
PubMed
Google Scholar
Zhang W, Finik J, Dana K, Glover V, Ham J, Nomura Y. Prenatal depression and infant temperament: the moderating role of placental gene expression. Infancy. 2018;23(2):211–31.
Article
PubMed
Google Scholar
Lahti-Pulkkinen M, Cudmore MJ, Haeussner E, Schmitz C, Pesonen AK, Hamalainen E, et al. Placental morphology is associated with maternal depressive symptoms during pregnancy and toddler psychiatric problems. Sci Rep. 2018;8(1):791.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry. 1987;150:782–6.
Article
CAS
PubMed
Google Scholar
Rubertsson C, Borjesson K, Berglund A, Josefsson A, Sydsjo G. The Swedish validation of Edinburgh postnatal depression scale (EPDS) during pregnancy. Nord J Psychiatry. 2011;65(6):414–8.
Article
PubMed
Google Scholar
Bergink V, Kooistra L. Lambregtse-van den berg MP, Wijnen H, Bunevicius R, van Baar a, et al. validation of the Edinburgh depression scale during pregnancy. J Psychosom Res. 2011;70(4):385–9.
Article
PubMed
Google Scholar
Ponder KL, Salisbury A, McGonnigal B, Laliberte A, Lester B, Padbury JF. Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming. Dev Psychobiol. 2011;53(7):711–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hannerfors AK, Hellgren C, Schijven D, Iliadis SI, Comasco E, Skalkidou A, et al. Treatment with serotonin reuptake inhibitors during pregnancy is associated with elevated corticotropin-releasing hormone levels. Psychoneuroendocrinology. 2015;58:104–13.
Article
CAS
PubMed
Google Scholar
Cottrell EC, Seckl JR, Holmes MC, Wyrwoll CS. Foetal and placental 11beta-HSD2: a hub for developmental programming. Acta Physiol (Oxf). 2014;210(2):288–95.
Article
CAS
Google Scholar
Hellgren C, Akerud H, Skalkidou A, Backstrom T, Sundstrom-Poromaa I. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology. 2014;69(3):147–53.
Article
CAS
PubMed
Google Scholar
Hellgren C, Comasco E, Skalkidou A, Sundstrom-Poromaa I. Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway. Horm Behav. 2017;94:106–13.
Article
CAS
PubMed
Google Scholar
Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–50.
Article
CAS
PubMed
Google Scholar
Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21(20):3798–807.
Article
CAS
PubMed
Google Scholar
John T, Liu G, Tsao MS. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. Oncogene. 2009;28(Suppl 1):S14–23.
Article
CAS
PubMed
Google Scholar
Reis M, Aamo T, Spigset O, Ahlner J. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit. 2009;31(1):42–56.
Article
CAS
PubMed
Google Scholar
Huang WQ, Zhang CL, Di XY, Zhang RQ. Studies on the localization of 5-hydroxytryptamine and its receptors in human placenta. Placenta. 1998;19(8):655–61.
Article
CAS
PubMed
Google Scholar
Velasquez JC, Goeden N, Bonnin A. Placental serotonin: implications for the developmental effects of SSRIs and maternal depression. Front Cell Neurosci. 2013;7:47.
Article
CAS
PubMed
PubMed Central
Google Scholar
St-Pierre J, Laurent L, King S, Vaillancourt C. Effects of prenatal maternal stress on serotonin and fetal development. Placenta. 2016;48(Suppl 1):S66–71.
Article
CAS
PubMed
Google Scholar
Paquette AG, Lesseur C, Armstrong DA, Koestler DC, Appleton AA, Lester BM, et al. Placental HTR2A methylation is associated with infant neurobehavioral outcomes. Epigenetics. 2013;8(8):796–801.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beck SG, Choi KC, List TJ. Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther. 1992;263(1):350–9.
CAS
PubMed
Google Scholar
Hamon M, Lanfumey L, el Mestikawy S, Boni C, Miquel MC, Bolanos F, et al. The main features of central 5-HT1 receptors. Neuropsychopharmacology. 1990;3(5–6):349–60.
CAS
PubMed
Google Scholar
Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, et al. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol. 2000;417(2):181–94.
Article
CAS
PubMed
Google Scholar
Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol. 2000;14(2):177–85.
Article
CAS
PubMed
Google Scholar
Briley M, Moret C. Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol. 1993;16(5):387–400.
Article
CAS
PubMed
Google Scholar
Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacol Ther. 2013;137(1):119–31.
Article
CAS
PubMed
Google Scholar
Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci. 2003;23(25):8788–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, et al. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm (Vienna). 2007;114(8):1065–8.
Article
CAS
Google Scholar
Albert PR, Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist. 2004;10(6):575–93.
Article
CAS
PubMed
Google Scholar
Olivier JD, Valles A, van Heesch F, Afrasiab-Middelman A, Roelofs JJ, Jonkers M, et al. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology. 2011;217(3):419–32.
Article
CAS
PubMed
Google Scholar
Leung K. [(18)F]Y1–973. Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD)2004.
Ortiz AA, Milardo LF, DeCarr LB, Buckholz TM, Mays MR, Claus TH, et al. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J Pharmacol Exp Ther. 2007;323(2):692–700.
Article
CAS
PubMed
Google Scholar
Paiva SP, Veloso CA, Campos FF, Carneiro MM, Tilan JU, Wang H, et al. Elevated levels of neuropeptide Y in preeclampsia: a pilot study implicating a role for stress in pathogenesis of the disease. Neuropeptides. 2016;55:127–35.
Article
CAS
PubMed
Google Scholar
Beloosesky R, Gayle DA, Amidi F, Ahanya SN, Desai M, Ross MG. Ontogenic expression of putative feeding peptides in the rat fetal brain and placenta. Nutr Neurosci. 2006;9(1–2):33–40.
Article
CAS
PubMed
Google Scholar
Roseboom PH, Nanda SA, Fox AS, Oler JA, Shackman AJ, Shelton SE, et al. Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism. Biol Psychiatry. 2014;76(11):850–7.
Article
CAS
PubMed
Google Scholar
El Marroun H, White T, Verhulst FC, Tiemeier H. Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review. Eur Child Adolesc Psychiatry. 2014;23(10):973–92.
Article
PubMed
Google Scholar
Lupattelli A, Spigset O, Bjornsdottir I, Hameen-Anttila K, Mardby AC, Panchaud A, et al. Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study. Depress Anxiety. 2015;32(6):426–36.
Article
PubMed
Google Scholar
Zoega H, Kieler H, Norgaard M, Furu K, Valdimarsdottir U, Brandt L, et al. Use of SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland, Norway and Sweden. Plos One. 2015;10(12):e0144474.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hellgren C, Edvinsson A, Olivier JD, Fornes R, Stener-Victorin E, Ubhayasekera SJ, et al. Tandem mass spectrometry determined maternal cortisone to cortisol ratio and psychiatric morbidity during pregnancy-interaction with birth weight. Psychoneuroendocrinology. 2016;69:142–9.
Article
CAS
PubMed
Google Scholar